HBM Healthcare Investments

The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India, China and other Emerging Markets. Their team supports the growth of the portfolio companies through all stages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
They seek to be a reliable and value-added financing partner for their companies. HBM Healthcare Investments, their main fund, invests in private and public companies as well as IPOs and is therefore ideally suited to support later-stage companies prior to a potential going public or trade sale.

Fund information

Investment areas

HBM Healthcare Investments Ltd actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas.

Other information

HBM Healthcare Investments holds and manages an international portfolio of promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).

Ways of communication
https://www.hbmpartners.com/en/kontakt/contact-form.php

Phone: +41 43 888 7171 Fax: +41 43 888 7172